These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9490895)

  • 1. [Parkinsonism induced by propiverine hydrochloride--report of 3 cases].
    Sugiyama Y
    Rinsho Shinkeigaku; 1997 Oct; 37(10):873-5. PubMed ID: 9490895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experience in the use of propiverine hydrochloride (P-4) for patients suffering from urinary frequency and/or incontinence].
    Yokoyama O; Miyazaki K; Ishida T; Fujita Y; Hisazumi H
    Hinyokika Kiyo; 1990 Apr; 36(4):517-23. PubMed ID: 2378310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The elderly patient with urge incontinence or urge-stress incontinence - efficacy and cardiac safety of propiverine].
    Dorschner W; Stolzenburg JU; Griebenow R; Halaska M; Brünjes R; Frank M; Wieners F
    Aktuelle Urol; 2003 Mar; 34(2):102-8. PubMed ID: 14566693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term administration study of propiverine hydrochloride (BUP-4 tablets) in pollakiuria and urinary incontinence].
    Noguchi K; Masuda M; Noguchi S; Kubota Y; Hosaka M; Senga Y; Sano K; Miyai K; Kanno H; Kitami K; Fujinami K; Miura T; Kondo I; Kawasaki C; Moriyama M; Hara Y; Ida T; Fukuoka H; Nakagawa J; Kitajima N; Fukuda M; Satomi Y; Takahashi T; Yamaguchi T; Shiozaki H
    Hinyokika Kiyo; 1998 Sep; 44(9):687-93. PubMed ID: 9805679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: a prospective randomized controlled study.
    Yokoyama T; Uematsu K; Watanabe T; Sasaki K; Kumon H; Nagai A;
    Scand J Urol Nephrol; 2009; 43(4):307-14. PubMed ID: 19396723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, tolerability and safety of propiverine hydrochloride in children and adolescents with congenital or traumatic neurogenic detrusor overactivity--a retrospective study.
    Grigoleit U; Mürtz G; Laschke S; Schuldt M; Goepel M; Kramer G; Stöhrer M
    Eur Urol; 2006 Jun; 49(6):1114-20; discussion 1120-1. PubMed ID: 16542772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Propiverine hydrochloride improved correlatively subjective QOL and objective findings in Japanese patients with urinary frequency and/or incontinence].
    Noguchi K; Yamagishi T; Suzuki K; Kondo K; Kishida T; Saito K; Sekiguchi Y; Nakaigawa N; Ogawa T; Uemura H; Yao M; Kubota Y; Kawai M; Okajima K; Kobayashi K; Moriyama M; Kinoshita Y; Mikata K; Kitami K; Masuda M; Saito R; Murai T; Tomoda T; Noguchi S; Sakai N; Hamano A; Nomura S; Sato K
    Hinyokika Kiyo; 2006 May; 52(5):343-8. PubMed ID: 16758722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and urodynamic effects of propiverine in patients suffering from urgency and urge incontinence. A multicentre dose-optimizing study.
    Mazur D; Wehnert J; Dorschner W; Schubert G; Herfurth G; Alken RG
    Scand J Urol Nephrol; 1995 Sep; 29(3):289-94. PubMed ID: 8578271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and urodynamic effects of oral propiverine therapy in neurogenic urinary incontinence. A multicenter study for optimizing dosage].
    Mazur D; Göcking K; Wehnert J; Schubert G; Herfurth G; Alken RG
    Urologe A; 1994 Sep; 33(5):447-52. PubMed ID: 7974935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Parkinsonism, depression and akathisia induced by flunarizine, a calcium entry blockade--report of 31 cases].
    Kuzuhara S; Kohara N; Ohkawa Y; Fuse S; Yamanouchi H
    Rinsho Shinkeigaku; 1989 Jun; 29(6):681-6. PubMed ID: 2582681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urodynamic effects of propiverine hydrochloride in children with neurogenic detrusor overactivity: a prospective analysis.
    Schulte-Baukloh H; Mürtz G; Henne T; Michael T; Miller K; Knispel HH
    BJU Int; 2006 Feb; 97(2):355-8. PubMed ID: 16430646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Valproate induced parkinsonism].
    Park-Matsumoto YC; Tazawa T
    No To Shinkei; 1998 Jan; 50(1):81-4. PubMed ID: 9493204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of propiverine hydrochloride on the function of the bladder in decerebrated dogs].
    Kaneko S; Kitazato K; Yamazaki Y; Okada H; Nagai M; Iriki M
    Nihon Yakurigaku Zasshi; 1990 Feb; 95(2):55-61. PubMed ID: 2328930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical effect of propiverine hydrochloride on urinary incontinence].
    Watanabe H; Uchida M; Kojima M
    Hinyokika Kiyo; 1998 Mar; 44(3):199-206. PubMed ID: 9589886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tolerance and effectiveness of propiverine hydrochloride in 752 patients with symptoms of detrusor hyperactivity and increased sensitivity and irritability of the urinary bladder: results of a study monitoring drug utilization].
    Halaska M; Martan A; Voigt R; Kaplan F; Raus K; Masata J; Klemenc J
    Ceska Gynekol; 1997 Oct; 62(5):259-64. PubMed ID: 9600163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propiverine compared to oxybutynin in neurogenic detrusor overactivity--results of a randomized, double-blind, multicenter clinical study.
    Stöhrer M; Mürtz G; Kramer G; Schnabel F; Arnold EP; Wyndaele JJ;
    Eur Urol; 2007 Jan; 51(1):235-42. PubMed ID: 16698176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and safety of propiverine on improvement of symptoms and QOL for female patients with wet overactive bladder].
    Kato M; Matsukawa Y; Kato K; Kondo A; Yamada S; Hattori R; Gotoh M
    Hinyokika Kiyo; 2008 Mar; 54(3):165-71. PubMed ID: 18411770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Trimetazidine-induced parkinsonism].
    Martí Massó JF
    Neurologia; 2004 Sep; 19(7):392-5. PubMed ID: 15273888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
    Goldenberg MM
    Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of drug-induced pneumonia caused by propiverine: follow-up drug lymphocyte stimulation test useful for identification of the suspected drug].
    Nakayama M; Bando M; Hosono T; Yamasawa H; Ohno S; Sugiyama Y
    Nihon Kokyuki Gakkai Zasshi; 2008 Apr; 46(4):336-40. PubMed ID: 18517000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.